[Market Sentiment]: Overall investor confidence and risk appetite influence demand for SKVB.F, driving prices up in bullish markets and down in bearish ones.

[Economic Conditions]: Macroeconomic factors like GDP growth, inflation, interest rates, and unemployment rates impact investor sentiment and corporate earnings, affecting SKVB.F's performance.

[Company Performance]: Novartis's financial health, including revenue, profitability, and debt levels, directly impacts SKVB.F as its stock price reflects the company's value.

[Industry Trends]: Developments in the pharmaceutical industry, such as new drug approvals, patent expirations, and regulatory changes, can affect Novartis and, consequently, SKVB.F.

[Currency Exchange Rates]: As a Swiss company listed in Frankfurt, fluctuations in the EUR/CHF exchange rate can impact the value of SKVB.F for investors outside Switzerland.

[Dividend Policy]: Novartis's dividend payouts and dividend yield affect investor demand for SKVB.F, as dividends can provide a return regardless of price movements.

[Competitor Actions]: Actions by Novartis's competitors, like Roche and Pfizer, including new product launches and market share gains, can affect Novartis's market position and, therefore, SKVB.F's price.

[Regulatory Environment]: Changes in pharmaceutical regulations, such as drug pricing policies or approval processes, can impact Novartis's operations and profitability, influencing SKVB.F's value.

[Geopolitical Events]: Global events like political instability, trade wars, or pandemics can affect market sentiment and supply chains, impacting Novartis and SKVB.F.

[Investor News and Analyst Ratings]: Positive news coverage, upgrades from analysts, and increased investor interest can boost demand for SKVB.F, while negative news or downgrades can lead to sell-offs.